AE

Ashique Elahi

Active Director Director DIN 10938620
DIN 10938620 First appointment Feb 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Feb 2025
Shareholding value Locked Premium profile

About Ashique Elahi

Ashique Elahi has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Israt Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10938620
Primary Designation Director
First Appointment 04 Feb 2025
Oldest Company Age 1 yrs

Current companies

Company Designation Appointment Founded Status
Director 04 Feb 2025 2025 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Israt Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ashique Elahi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashique Elahi

Ashique Elahi has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Israt Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Ashique Elahi is associated with 1 company as Director.

Ashique Elahi has expertise in General Business.

Ashique Elahi has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available